Post #10516

💊🇺🇸FDA APPROVES FOUNDAYO OBESITY DRUG APRIL 1 🔹Foundayo orforglipron approved for weight reduction in obese adults with diet exercise 💊 🔹11 novel drugs approved through April covering rare diseases and cancer treatments 📈 🔹Baxdrostat hypertension drug under Priority Review — breakthrough for resistant blood pressure 🩺 🔹Advisory Committee April 30 reviews breast cancer and prostate cancer therapies pending 🏥 🔹Breakthrough designations for blood cancers and Hunter syndrome advancing pipeline 🔬 American pharma innovation conquering diseases — FDA fast-tracking breakthroughs! 🇺🇸⚡ #FDA#healthcare @america